Have More USP <797> Questions? Register for a SECOND Frontline Conversations Session on Adult and Pediatric Compounding
![]() |
|
An Event So Nice, We're Hosting it Twice! Ask Our Expert Faculty Your Questions on USP <797> |
Frontline Conversations: USP <797> Considerations for Safe Sterile Compounding in Adult and Pediatric Patients |
|
![]() |
|
Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This Frontline Conversations session will focus on special considerations for adult versus pediatric sterile compounding with expert faculty. This session follows a live webinar that summarized strategies to bring back or increase sterile compounding in healthcare facilities and special considerations for compounded sterile products (CSPs) for adult versus pediatric populations. This session also follows an interactive, web-based educational program that focused on assigning beyond use dates for CSPs..
No formal presentation is planned for this session. Please bring your question(s) for our faculty experts. Tuesday, July 211–2 p.m. ET |
|
|
We invite you to share this free educational activity with your colleagues. Registration is required for the session. |
How It Works:
|
Featuring... |
![]() |
Patricia C. KienleMPA, BCSCP, FASHP
Director, Accreditation and Medication Safety |
![]() |
Cynthia A. BrasherPharmD, MS, BCSCP
Manager of Compounding |
![]() |
Jaclyn M. JaskowiakPharmD, BCPS, BCSCP
Inpatient Pharmacist Specialist, Compounding Compliance and Operations |
Target AudienceThis activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems, including all settings responsible for preparing, labeling, packaging, storing, and distributing compounded sterile preparations. |
Please NoteCE Credit: There is no CE credit with this activity. Activity Fee: No charge
|
![]() |
|
Provided by ASHP. For questions and assistance to participate, contact us. |





